Hasil Pencarian - Thijs Hendrikx
- Menampilkan 1 - 5 hasil dari 5
-
1
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 oleh René Westhovens, Thijs Hendrikx, Beatrix Bartok, Cécile Gaujoux-Viala, Giovanni Adami, Zhaoyu Yin, Ying Guo, Osvaldo Daniel Messina, Alan Matsumoto
Diterbitkan 2021-07-01
Artikel -
2
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to con... oleh Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu
Diterbitkan 2019-06-01
Artikel -
3
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease oleh Philip Helliwell, Laura C. Coates, Oliver FitzGerald, Peter Nash, Enrique R. Soriano, M. Elaine Husni, Ming-Ann Hsu, Keith S. Kanik, Thijs Hendrikx, Joseph Wu, Elizabeth Kudlacz
Diterbitkan 2018-10-01
Artikel -
4
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies oleh Peter Nash, Laura C. Coates, Roy Fleischmann, Kim A. Papp, Juan Jesus Gomez-Reino, Keith S. Kanik, Cunshan Wang, Joseph Wu, Sujatha Menon, Thijs Hendrikx, William C. Ports
Diterbitkan 2018-11-01
Artikel -
5
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, ran... oleh Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu, Linda Chen, Elizabeth Kudlacz, Joseph Wu
Diterbitkan 2019-06-01
Artikel